Cargando…

3D Raman imaging of systemic endothelial dysfunction in the murine model of metastatic breast cancer

It was recently reported in the murine model of metastatic breast cancer (4T1) that tumor progression and development of metastasis is associated with systemic endothelial dysfunction characterized by impaired nitric oxide (NO) production. Using Raman 3D confocal imaging with the analysis of the ind...

Descripción completa

Detalles Bibliográficos
Autores principales: Pacia, Marta Z., Buczek, Elzbieta, Blazejczyk, Agnieszka, Gregorius, Aleksandra, Wietrzyk, Joanna, Chlopicki, Stefan, Baranska, Malgorzata, Kaczor, Agnieszka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837206/
https://www.ncbi.nlm.nih.gov/pubmed/26935932
http://dx.doi.org/10.1007/s00216-016-9436-9
_version_ 1782427812227973120
author Pacia, Marta Z.
Buczek, Elzbieta
Blazejczyk, Agnieszka
Gregorius, Aleksandra
Wietrzyk, Joanna
Chlopicki, Stefan
Baranska, Malgorzata
Kaczor, Agnieszka
author_facet Pacia, Marta Z.
Buczek, Elzbieta
Blazejczyk, Agnieszka
Gregorius, Aleksandra
Wietrzyk, Joanna
Chlopicki, Stefan
Baranska, Malgorzata
Kaczor, Agnieszka
author_sort Pacia, Marta Z.
collection PubMed
description It was recently reported in the murine model of metastatic breast cancer (4T1) that tumor progression and development of metastasis is associated with systemic endothelial dysfunction characterized by impaired nitric oxide (NO) production. Using Raman 3D confocal imaging with the analysis of the individual layers of the vascular wall combined with AFM endothelial surface imaging, we demonstrated that metastasis-induced systemic endothelial dysfunction resulted in distinct chemical changes in the endothelium of the aorta. These changes, manifested as a significant increase in the protein content (18 %) and a slight decrease in the lipid content (4 %), were limited to the endothelium and did not occur in the deeper layers of the vascular wall. The altered lipid to protein ratio in the endothelium, although more pronounced in the fixed vascular wall, was also observed in the freshly isolated unfixed vascular wall samples in the aqueous environment (12 and 7 % change of protein and lipid content, respectively). Our results support the finding that the metastasis induces systemic endothelial dysfunction that may contribute to cancer progression. [Figure: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00216-016-9436-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4837206
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-48372062016-05-04 3D Raman imaging of systemic endothelial dysfunction in the murine model of metastatic breast cancer Pacia, Marta Z. Buczek, Elzbieta Blazejczyk, Agnieszka Gregorius, Aleksandra Wietrzyk, Joanna Chlopicki, Stefan Baranska, Malgorzata Kaczor, Agnieszka Anal Bioanal Chem Rapid Communication It was recently reported in the murine model of metastatic breast cancer (4T1) that tumor progression and development of metastasis is associated with systemic endothelial dysfunction characterized by impaired nitric oxide (NO) production. Using Raman 3D confocal imaging with the analysis of the individual layers of the vascular wall combined with AFM endothelial surface imaging, we demonstrated that metastasis-induced systemic endothelial dysfunction resulted in distinct chemical changes in the endothelium of the aorta. These changes, manifested as a significant increase in the protein content (18 %) and a slight decrease in the lipid content (4 %), were limited to the endothelium and did not occur in the deeper layers of the vascular wall. The altered lipid to protein ratio in the endothelium, although more pronounced in the fixed vascular wall, was also observed in the freshly isolated unfixed vascular wall samples in the aqueous environment (12 and 7 % change of protein and lipid content, respectively). Our results support the finding that the metastasis induces systemic endothelial dysfunction that may contribute to cancer progression. [Figure: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00216-016-9436-9) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2016-03-02 2016 /pmc/articles/PMC4837206/ /pubmed/26935932 http://dx.doi.org/10.1007/s00216-016-9436-9 Text en © The Author(s) 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Rapid Communication
Pacia, Marta Z.
Buczek, Elzbieta
Blazejczyk, Agnieszka
Gregorius, Aleksandra
Wietrzyk, Joanna
Chlopicki, Stefan
Baranska, Malgorzata
Kaczor, Agnieszka
3D Raman imaging of systemic endothelial dysfunction in the murine model of metastatic breast cancer
title 3D Raman imaging of systemic endothelial dysfunction in the murine model of metastatic breast cancer
title_full 3D Raman imaging of systemic endothelial dysfunction in the murine model of metastatic breast cancer
title_fullStr 3D Raman imaging of systemic endothelial dysfunction in the murine model of metastatic breast cancer
title_full_unstemmed 3D Raman imaging of systemic endothelial dysfunction in the murine model of metastatic breast cancer
title_short 3D Raman imaging of systemic endothelial dysfunction in the murine model of metastatic breast cancer
title_sort 3d raman imaging of systemic endothelial dysfunction in the murine model of metastatic breast cancer
topic Rapid Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837206/
https://www.ncbi.nlm.nih.gov/pubmed/26935932
http://dx.doi.org/10.1007/s00216-016-9436-9
work_keys_str_mv AT paciamartaz 3dramanimagingofsystemicendothelialdysfunctioninthemurinemodelofmetastaticbreastcancer
AT buczekelzbieta 3dramanimagingofsystemicendothelialdysfunctioninthemurinemodelofmetastaticbreastcancer
AT blazejczykagnieszka 3dramanimagingofsystemicendothelialdysfunctioninthemurinemodelofmetastaticbreastcancer
AT gregoriusaleksandra 3dramanimagingofsystemicendothelialdysfunctioninthemurinemodelofmetastaticbreastcancer
AT wietrzykjoanna 3dramanimagingofsystemicendothelialdysfunctioninthemurinemodelofmetastaticbreastcancer
AT chlopickistefan 3dramanimagingofsystemicendothelialdysfunctioninthemurinemodelofmetastaticbreastcancer
AT baranskamalgorzata 3dramanimagingofsystemicendothelialdysfunctioninthemurinemodelofmetastaticbreastcancer
AT kaczoragnieszka 3dramanimagingofsystemicendothelialdysfunctioninthemurinemodelofmetastaticbreastcancer